These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9865665)

  • 1. Genetic markers: genes involved in thrombosis.
    Wu KK
    J Cardiovasc Risk; 1997; 4(5-6):347-52. PubMed ID: 9865665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred.
    Scott BT; Bovill EG; Callas PW; Hasstedt SJ; Leppert MF; Valliere JE; Varvil TS; Long GL
    Thromb Haemost; 2001 Jan; 85(1):82-7. PubMed ID: 11204593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic risk factors in myocardial infarction at young age.
    Incalcaterra E; Hoffmann E; Averna MR; Caimi G
    Minerva Cardioangiol; 2004 Aug; 52(4):287-312. PubMed ID: 15284679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic genetic markers.
    Rossi ML; Merlini PA; Ardissino D
    Ital Heart J; 2001 Jul; 2(7):495-8. PubMed ID: 11501956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of the fibrinogen beta-chain, angiotensin-converting enzyme and plasminogen activator inhibitor-1 polymorphisms in Costa Rican young adults with thrombotic disease.
    Hidalgo A; Salazar-Sanchez L; Cartin M; Mendez M; Arauz J; Parajeles A
    Cell Biochem Funct; 2010 Jul; 28(5):367-73. PubMed ID: 20535834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
    Tóth O; Dávid M; Habon T; Nagy A; Keszthelyi Z; Kovács N; Losonczy H
    Orv Hetil; 2005 Oct; 146(41):2121-5. PubMed ID: 16304806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vein thrombosis in a newborn with prothrombotic genetic risk factors.
    Giordano P; Laforgia N; Di Giulio G; Storelli S; Mautone A; Iolascon A
    J Perinat Med; 2001; 29(2):163-6. PubMed ID: 11344677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombophilias associated with cerebral venous thrombosis].
    Schlück E; Rodier G; Derouiche F; Bronner P; Boulay C; Courtois S; Cohen E
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):543-52. PubMed ID: 12072822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and prevalence of prothrombotic single nucleotide polymorphism profiles in the Greek Cypriot population.
    Xenophontos SL; Hadjivassiliou M; Ayrton N; Karagrigoriou A; Pantzaris M; Nicolaides AN; Cariolou MA
    Int Angiol; 2002 Dec; 21(4):322-9. PubMed ID: 12518110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inherited thrombophilia and arterial diseases].
    Robert-Ebadi H; Boehlen F; de Moerloose P
    Rev Med Suisse; 2007 Feb; 3(97):331-2, 334-5. PubMed ID: 17370730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia: Part 1.
    Lane DA; Mannucci PM; Bauer KA; Bertina RM; Bochkov NP; Boulyjenkov V; Chandy M; Dahlbäck B; Ginter EK; Miletich JP; Rosendaal FR; Seligsohn U
    Thromb Haemost; 1996 Nov; 76(5):651-62. PubMed ID: 8950768
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.
    Tsantes AE; Nikolopoulos GK; Bagos PG; Bonovas S; Kopterides P; Vaiopoulos G
    Thromb Res; 2008; 122(6):736-42. PubMed ID: 17949795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population.
    Hoppe B; Tolou F; Dörner T; Kiesewetter H; Salama A
    Thromb Haemost; 2006 Oct; 96(4):465-70. PubMed ID: 17003923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
    Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
    Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of thrombotic children with malignancy.
    Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic risk factors and arterial thrombotic disease.
    Reiner AP; Siscovick DS; Rosendaal FR
    Thromb Haemost; 2001 Apr; 85(4):584-95. PubMed ID: 11341490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Genetic variations in plasminogen activator inhibitor-1 gene and beta fibrinogen gene associated with glomerular microthrombosis in lupus nephritis and the gene dosage effect].
    Gong R; Liu Z; Chen Z; Li L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):1-5. PubMed ID: 11836675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.